Satsuma Pharmaceuticals, Inc. Operating Income
Satsuma Pharmaceuticals, Inc. reported Operating Income of -$10.77 million for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-11.
Discontinued › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2023-05-11
- Satsuma Pharmaceuticals, Inc. operating income (loss) for the quarter ending 2023-03-31 was -$10.77M.
- Satsuma Pharmaceuticals, Inc. operating income (loss) for the quarter ending 2022-12-31 was -$23.59M.
- Satsuma Pharmaceuticals, Inc. operating income (loss) for the quarter ending 2022-09-30 was -$15.41M.
- Satsuma Pharmaceuticals, Inc. operating income (loss) for the quarter ending 2022-06-30 was -$16.40M.
- Satsuma Pharmaceuticals, Inc. operating income (loss) for fiscal 2022 was -$70.95M.
- Satsuma Pharmaceuticals, Inc. operating income (loss) for fiscal 2021 was -$51.17M.
- Satsuma Pharmaceuticals, Inc. operating income (loss) for fiscal 2020 was -$48.33M.
- Satsuma Pharmaceuticals, Inc. operating income (loss) for fiscal 2019 was -$28.88M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|
| 2023-03-31 | -$10.77M 10-Q · filed 2023-05-11 | -$34.36M derived: sum of 2 quarters · filed 2023-05-11 | -$49.77M derived: sum of 3 quarters · filed 2023-05-11 | -$66.17M derived: sum of 4 quarters · filed 2023-05-11 |
| 2022-12-31 | -$23.59M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | -$39.00M derived: sum of 2 quarters · filed 2023-03-28 | -$55.40M derived: sum of 3 quarters · filed 2023-03-28 | -$70.95M 10-K · filed 2023-03-28 |
| 2022-09-30 | -$15.41M 10-Q · filed 2022-11-03 | -$31.81M derived: sum of 2 quarters · filed 2022-11-03 | -$47.35M 10-Q · filed 2022-11-03 | -$62.91M derived: sum of 4 quarters · filed 2023-05-11 |
| 2022-06-30 | -$16.40M 10-Q · filed 2022-08-09 | -$31.95M 10-Q · filed 2022-08-09 | -$47.51M derived: sum of 3 quarters · filed 2023-05-11 | -$60.84M derived: sum of 4 quarters · filed 2023-05-11 |
| 2022-03-31 | -$15.55M 10-Q · filed 2023-05-11 | -$31.11M derived: sum of 2 quarters · filed 2023-05-11 | -$44.44M derived: sum of 3 quarters · filed 2023-05-11 | -$56.26M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | -$15.56M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | -$28.89M derived: sum of 2 quarters · filed 2023-03-28 | -$40.72M derived: sum of 3 quarters · filed 2023-03-28 | -$51.17M 10-K · filed 2023-03-28 |
| 2021-09-30 | -$13.33M 10-Q · filed 2022-11-03 | -$25.16M derived: sum of 2 quarters · filed 2022-11-03 | -$35.61M 10-Q · filed 2022-11-03 | -$48.09M derived: sum of 4 quarters · filed 2022-11-03 |
| 2021-06-30 | -$11.83M 10-Q · filed 2022-08-09 | -$22.28M 10-Q · filed 2022-08-09 | -$34.76M derived: sum of 3 quarters · filed 2022-08-09 | -$46.93M derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | -$10.45M 10-Q · filed 2022-05-10 | -$22.94M derived: sum of 2 quarters · filed 2022-05-10 | -$35.11M derived: sum of 3 quarters · filed 2022-05-10 | -$46.61M derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | -$12.49M 10-K · filed 2021-03-25 | -$24.66M derived: sum of 2 quarters · filed 2021-11-09 | -$36.16M derived: sum of 3 quarters · filed 2021-11-09 | -$48.33M 10-K · filed 2022-03-15 |
| 2020-09-30 | -$12.17M 10-Q · filed 2021-11-09 | -$23.67M derived: sum of 2 quarters · filed 2021-11-09 | -$35.84M 10-Q · filed 2021-11-09 | -$47.12M derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | -$11.50M 10-Q · filed 2021-08-10 | -$23.67M 10-Q · filed 2021-08-10 | -$34.95M derived: sum of 3 quarters · filed 2021-08-10 | -$43.42M derived: sum of 4 quarters · filed 2021-08-10 |
| 2020-03-31 | -$12.17M 10-Q · filed 2021-05-11 | -$23.45M derived: sum of 2 quarters · filed 2021-05-11 | -$31.92M derived: sum of 3 quarters · filed 2021-05-11 | -$38.34M derived: sum of 4 quarters · filed 2021-05-11 |
| 2019-12-31 | -$11.28M 10-K · filed 2021-03-25 | -$19.75M derived: sum of 2 quarters · filed 2021-03-25 | -$26.17M derived: sum of 3 quarters · filed 2021-03-25 | -$28.88M 10-K · filed 2021-03-25 |
| 2019-09-30 | -$8.47M 10-K · filed 2021-03-25 | -$14.89M derived: sum of 2 quarters · filed 2021-03-25 | -$17.61M 10-Q · filed 2020-11-10 | -$19.89M derived: sum of 4 quarters · filed 2021-03-25 |
| 2019-06-30 | -$6.42M 10-K · filed 2021-03-25 | -$9.14M 10-Q · filed 2020-08-11 | -$11.42M derived: sum of 3 quarters · filed 2021-03-25 | -$13.02M derived: sum of 4 quarters · filed 2021-03-25 |
| 2019-03-31 | -$2.71M 10-K · filed 2021-03-25 | -$5.00M derived: sum of 2 quarters · filed 2021-03-25 | -$6.60M derived: sum of 3 quarters · filed 2021-03-25 | -$8.82M derived: sum of 4 quarters · filed 2021-03-25 |
| 2018-12-31 | -$2.28M 10-K · filed 2020-03-10 | -$3.88M derived: sum of 2 quarters · filed 2020-03-10 | -$6.11M derived: sum of 3 quarters · filed 2020-03-10 | -$7.51M 10-K · filed 2020-03-10 |
| 2018-09-30 | -$1.60M 10-K · filed 2020-03-10 | -$3.82M derived: sum of 2 quarters · filed 2020-03-10 | -$5.23M 10-Q · filed 2019-11-12 | |
| 2018-06-30 | -$2.22M 10-K · filed 2020-03-10 | -$3.63M derived: sum of 2 quarters · filed 2020-03-10 | ||
| 2018-03-31 | -$1.41M 10-K · filed 2020-03-10 | |||
| 2017-12-31 | -$4.95M 10-K · filed 2020-03-10 |